Quantcast

Posts related to ‘NFLD’

newspaper

The Unusual Suspects (X, BRK-A, BNI, NFLD, INTC, WIND, AAPL, PALM, NVAX)

Posted: June 7, 2009 at 6:31 am

There were several unusual occurrences at the end of the week and some we saw over the weekend screenings for items missed during the week.  These will also be among ...
Read Full Story »
Burning Money Pic

Many Biotechs Barely On Life Support (BPAX, CEGE, EPIX, IDMI, LJPC, NRGN, NFLD, TPTX)

Posted: May 13, 2009 at 11:31 am

We have run a watch list of companies under their own strategic review, and the number of biotech (or grouped with biotech) stocks under this description is just staggering.   We ...
Read Full Story »

Short Selling Volatile Biotechs (June 2007) (DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVO)

Posted: June 27, 2007 at 12:36 pm

Stock Tickers: DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVOMany of the recent biotech implosions are always interesting to see if short sellers are getting out of the way or ...
Read Full Story »

Cramer’s Three Biotech Picks, And His Biotech Strategy

Posted: May 29, 2007 at 11:39 am

Stock Tickers: DNA, AMGN, NFLD, CELG, GILD, GENZ, ONXX, DNDNJim Cramer has a video on TheStreet.com "Wall St. Confidential" showing how the biotech sector can be looked at with blow-ups.  ...
Read Full Story »

Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)

Posted: May 25, 2007 at 7:24 am

Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLDThe short interest is on the rise overall, but the odd thing is that the short interest in biotech ...
Read Full Story »

Northfield Laboratories Turns Into a Zombie (NFLD)

Posted: May 24, 2007 at 3:01 pm

Northfield Laboratories Inc. (NFLD-NASDAQ) has probably just joined the ranks of the biotech zombies after the drop witnessed yesterday and today.The truth is that this may not be a true ...
Read Full Story »

Northfield Labs Heads Permanently South

Posted: May 23, 2007 at 7:49 am

Northfield Labs (NFLD-NASDAQ) just faced what may the knockout blow for the company.  The company has been working for years now on studies for PolyHeme, its blood substitution product.  This ...
Read Full Story »